Kliniske forsøg med Anti-PD-1 antistof
I alt 283 resultater
-
University Hospital, MontpellierAfsluttetPatienter, der modtager anti-PD-1 eller Anti-PD-L1 immunterapierFrankrig
-
Ningbo Cancer HospitalUkendtAvancerede maligniteter | PD-1 antistof | CAR-T cellerKina
-
Shanghai International Medical CenterUkendtAvanceret solid tumor | PD-1 antistof | CAR-T cellerKina
-
Chinese PLA General HospitalRekrutteringHodgkin lymfom | Anti-PD-1 antistof resistentKina
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
West China HospitalFirst Affiliated Hospital of Chongqing Medical University; Sichuan Cancer... og andre samarbejdspartnereRekrutteringEndetarmskræft | Strålebehandling | Anti-PD-1 antistof | MSI-H | Mmr MangelKina
-
Peking Union Medical College HospitalRekrutteringAnlotinib | Anti-PD-1 antistof | Avanceret kræft i bugspytkirtlenKina
-
Lei LiAfsluttetKemoterapi | Tilbagevendende cervikal karcinom | Immunterapi | Anti-PD-1 antistof | Vedvarende avanceret cervikal karcinomKina
-
Beijing Friendship HospitalAfsluttetGaldevejskræft | Capecitabin | Målrettet molekylær terapi | Anti-PD-1 terapiKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuMavekræft, HIPEC, Anti-PD-1 antistof Camrelizumab (SHR-1210), kemoterapi og kirurgiKina
-
Guohui LiRekrutteringPD-1 | Immunrelaterede bivirkningerKina
-
Merck Sharp & Dohme LLCRekrutteringIkke-småcellet lungekræft | Faste tumorer | Programmeret celledød-1 (PD1, PD-1) | Programmeret celledød 1 Ligand 1 (PDL1, PD-L1) | Programmeret celledød 1 ligand 2 (PDL2, PD-L2)Japan
-
Sun Yat-sen UniversityRekrutteringImmunterapi | DMMR tyktarmskræft | Anti PD-1Kina
-
Ascendis Pharma Oncology Division A/SRekrutteringAvanceret solid tumor | Metastatisk fast tumor | Platin-resistent kræft i æggestokkene | Lokalt avanceret solid tumor | Post Anti-PD-1 melanom | 2L+ livmoderhalskræft | Neoadjuverende melanom | Neoadjuverende ikke-småcellet lungekræft | Post Anti-PD-(L)1 ikke-småcellet lungekræft | Post Anti-PD-(L)1 småcellet...Forenede Stater, Australien, Korea, Republikken
-
Lei LiRekrutteringKemoterapi | Tilbagevendende cervikal karcinom | Immune Checkpoint-hæmmere | Anti-PD-1 antistof | Vedvarende avanceret cervikal karcinom | Albumin-bundet PaclitaxelKina
-
Shanghai Jiao Tong University School of MedicineRekrutteringOralt planocellulært karcinom | Anti-PD-1 | Neoadjvant terapi | Anti-VEGFRKina
-
Peking UniversityIkke rekrutterer endnuGastroøsofageal Junction Cancer | Kemoradioterapi | PD-1
-
The First Hospital of Jilin UniversityIkke rekrutterer endnuLokalt avanceret endetarmskræft | Anti-PD-1 | Total Neoadjuverende behandlingKina
-
Sichuan Cancer Hospital and Research InstituteIkke rekrutterer endnuIntrahepatisk cholangiocarcinom | Apatinib | PD-1 antistof | Transarteriel kemoemboliseringKina
-
Agenus Inc.AfsluttetAvancerede solide kræftformer | Advanced Solid Cancers Refractory to PD-1Forenede Stater
-
Shanghai Zhongshan HospitalAktiv, ikke rekrutterendeGaldevejskræft | PD-1 antistof | Lenvatinib | GemoxKina
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | G-CSFKina
-
China Medical University, ChinaIkke rekrutterer endnuPD-1 antistof | Gastrointestinale tumorer | DC-celle | NK-celle
-
Shanghai Jiao Tong University School of MedicineRekrutteringKemoterapi | Oralt planocellulært karcinom | Anti-PD-1 | Neoadjvant terapiKina
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest...Ikke rekrutterer endnuKronisk hepatitis b | Anti-PD-1 antistofKina
-
Tibotec Pharmaceuticals, IrelandAfsluttet
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest...Ikke rekrutterer endnuKronisk hepatitis b | Anti-PD-1 antistof | Peg-IFNaKina
-
Shandong New Time Pharmaceutical Co., LTDIkke rekrutterer endnu
-
Baodong QinUkendtKemoterapi effekt | Immunterapi | Tumormutationsbyrde | PD-1/L1-hæmmerKina
-
Xuanwu Hospital, BeijingUkendtIkke-småcellet lungekræft | PD-1 antistof | Lungekræft fase II
-
Icahn School of Medicine at Mount SinaiRekrutteringKræft | Skjoldbruskkirtel | PD-1Forenede Stater
-
Jiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterendeKemoterapi effekt | Lungekræft fase IV | PD-1 antistof | Lungekræft pladecelleKina
-
Lei LiUkendtKemoterapi | Tilbagevendende cervikal karcinom | Bivirkningshændelse | Cervikal neuroendokrin karcinom | Objektiv svarprocent | Avanceret livmoderhalskræft | Anti-pd-1 antistofKina
-
Xijing HospitalRekrutteringPD-1 | Lokalt avanceret gastrisk adenocarcinomKina
-
Wuhan Union Hospital, ChinaRekrutteringGastroøsofageal Junction Cancer | PD-1 | Neoadjuverende kemoradioterapiKina
-
RenJi HospitalRekrutteringØvre urinvejsurothelial karcinom | Nyrekonservering | HER-2 ADC | PD-1 antistofKina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RekrutteringRefraktær MSI - H faste tumorer forud for PD-(L) 1-terapi | MSI-H tumorerForenede Stater
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | Granulocytkoloni-stimulerende faktorKina
-
University of BernNovartis; University Hospital Inselspital, Berne; Schweizerische Multiple... og andre samarbejdspartnereRekrutteringMultipel sclerose | Optisk neuritis | Neuromyelitis Optica Spectrum Disorder | CNS sarkoidose | CNS vaskulitis | Tværgående myelitis | Rasmussen Encephalitis | Akut dissemineret encephalomyelitis | Anti-NMDAR Encephalitis | Anti-GAD65 Associeret Autoimmun Encephalitis | Anti-AMPAR-1/2 Associeret Autoimmun Encephalitis og andre forholdSchweiz
-
Second Affiliated Hospital, School of Medicine,...RekrutteringLivmoderhalskræft | Neoadjuverende kemoterapi | Anti-PD-1 | Neoadjuverende immunterapiKina
-
Z Factor LimitedHammersmith Medicines Research; Centessa Pharmaceuticals plcAfsluttetEn enkelt stigende og gentagen dosisundersøgelse af oral ZF874 hos raske frivillige og PiXZ-personerAlpha1 Anti-Trypsin mangelDet Forenede Kongerige
-
West China HospitalRekrutteringBRAF V600E-muteret /MSS Metastatisk kolorektal cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) kombineret med PD-1 monoklonalt antistofKina
-
Ascletis Pharmaceuticals Co., Ltd.RekrutteringHIV-infektioner | HIV-1-infektion | PD-L1 genmutationKina
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Chest HospitalUkendtKemoterapi effekt | KRAS genmutation | NSCLC trin IV | PD-1 antistof
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRekruttering
-
Sun Yat-sen UniversityAfsluttetHjernemetastaser | NSCLC trin IV | PD-1 antistofKina
-
RenJi HospitalRekrutteringStrålebehandling | Muskelinvasiv blærekræft | PD-1 | HER2 udtryk | Antistof-lægemiddelkonjugaterKina
-
Shanghai Jiao Tong University Affiliated Sixth...RekrutteringLivmoderhalskræft | Strålebehandling | Neoadjuverende kemoterapi | PD-1 antistofKina